DE69230590D1 - Mittel gegen fettleibigkeit - Google Patents

Mittel gegen fettleibigkeit

Info

Publication number
DE69230590D1
DE69230590D1 DE69230590T DE69230590T DE69230590D1 DE 69230590 D1 DE69230590 D1 DE 69230590D1 DE 69230590 T DE69230590 T DE 69230590T DE 69230590 T DE69230590 T DE 69230590T DE 69230590 D1 DE69230590 D1 DE 69230590D1
Authority
DE
Germany
Prior art keywords
agent against
against obesity
obesity
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230590T
Other languages
English (en)
Other versions
DE69230590T2 (de
Inventor
Kunio Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN
Original Assignee
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN filed Critical RIKEN
Publication of DE69230590D1 publication Critical patent/DE69230590D1/de
Application granted granted Critical
Publication of DE69230590T2 publication Critical patent/DE69230590T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69230590T 1991-12-20 1992-12-17 Mittel gegen fettleibigkeit Expired - Fee Related DE69230590T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3338916A JP3029907B2 (ja) 1991-12-20 1991-12-20 抗肥満剤
PCT/JP1992/001642 WO1993012798A1 (en) 1991-12-20 1992-12-17 Obesity inhibitor

Publications (2)

Publication Number Publication Date
DE69230590D1 true DE69230590D1 (de) 2000-02-24
DE69230590T2 DE69230590T2 (de) 2000-05-31

Family

ID=18322543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230590T Expired - Fee Related DE69230590T2 (de) 1991-12-20 1992-12-17 Mittel gegen fettleibigkeit

Country Status (7)

Country Link
US (2) US5420121A (de)
EP (1) EP0617962B1 (de)
JP (1) JP3029907B2 (de)
AU (1) AU3170893A (de)
CA (1) CA2126208C (de)
DE (1) DE69230590T2 (de)
WO (1) WO1993012798A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US6531462B2 (en) 1997-11-06 2003-03-11 Riken Medicament for treating obesity and improving lipid metabolism
JP3873097B2 (ja) * 1997-11-06 2007-01-24 独立行政法人理化学研究所 抗肥満剤及び脂質代謝改善剤
AU2003225277A1 (en) * 2002-05-02 2003-11-17 Robert Harris Lipid removal from the body
KR20090120018A (ko) 2005-09-22 2009-11-23 모리나가 뉴교 가부시키가이샤 내장 지방 축적 억제제
KR100935813B1 (ko) 2005-09-22 2010-01-08 모리나가 뉴교 가부시키가이샤 내장 지방 축적 억제제
CN104603617B (zh) * 2012-05-18 2017-04-12 Dh科技发展私人贸易有限公司 使用定点衍生化和lc/ms/ms工作流程分析一组脑腱黄瘤病生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS552277B2 (de) * 1974-12-27 1980-01-19
US4088760A (en) * 1976-06-23 1978-05-09 Richardson-Merrell Inc. Testosterone 5α-reductase inhibitors
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
US4680289A (en) * 1985-06-05 1987-07-14 Progenics, Inc. Treatment of obesity and diabetes using sapogenins
IE58540B1 (en) * 1985-08-02 1993-10-06 Research Corp Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents

Also Published As

Publication number Publication date
CA2126208C (en) 1997-08-19
US5610152A (en) 1997-03-11
AU3170893A (en) 1993-07-28
EP0617962A4 (de) 1994-12-07
EP0617962B1 (de) 2000-01-19
US5420121A (en) 1995-05-30
JPH05170651A (ja) 1993-07-09
WO1993012798A1 (en) 1993-07-08
DE69230590T2 (de) 2000-05-31
EP0617962A1 (de) 1994-10-05
CA2126208A1 (en) 1993-07-08
JP3029907B2 (ja) 2000-04-10

Similar Documents

Publication Publication Date Title
BR9402181A (pt) Dispositivo médico
DK0783302T3 (da) Lægemidler
DE59409409D1 (de) Inhalationsgerät
NO933601D0 (no) Forbedret ligningsbasert treklebemiddel
FI945312A (fi) Kerroskuvaus-röntgenlaite
NO921189L (no) Todelt ostomi-anordning
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
DE69509966D1 (de) Badevorrichtung
DE69501923D1 (de) Blockiervorrichtung
DE69230590D1 (de) Mittel gegen fettleibigkeit
SE9303369L (sv) Respiratorisk anordning
BR9205281A (pt) Pentapeptideos imuno-reguladores e neuro-reguladores
DE69422496D1 (de) Mittel gegen malaria
DE59510194D1 (de) Dose
DE69413856D1 (de) Röntgeneinrichtung
KR940022958U (ko) 욕실용 환풍기
KR950005295U (ko) 부구 결속구
DE59409895D1 (de) Rückflussverhinderungseinrichtung
KR940025597U (ko) 콘센트의 안전장치
DK0631754T3 (da) Badekar
KR950002778U (ko) 다목적 수건
KR940021335U (ko) 용액 역류 방지장치
KR950015004U (ko) 과열방지장치
FI1246U1 (fi) En slips
DK134193D0 (da) Personvender

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee